Is Irisin an Anticarcinogenic Peptide?

dc.contributor.authorTekin, Suat
dc.contributor.authorErden, Yavuz
dc.contributor.authorYılmaz, Bayram
dc.date.accessioned2021-12-03T10:10:27Z
dc.date.available2021-12-03T10:10:27Z
dc.date.issued2015
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: Irisin is thought an anti obesity hormone, which regulates body weight and metabolism, including insulin resistance. It is known that obesity is a risk factor in the development of cancer. This study was designed to evaluate whether there is a role of irisin on viability of human prostate cancer cells. In the present study, 0.1, 1, 10 and 100 nM concentrations of irisin were applied to human prostate cancer cells with androgen receptor positive (LNCaP) and androgen receptor negative (DU-145, PC3). Effects of irisin were determined using 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. At the end of study, all concentrations of irisin reduced viability in the three types of prostate cells, but only 10 and 100 nM concentrations of the irisin caused a significant decreases (p<0.05). Consequently, high concentrations of irisin in both androgen receptor positive and androgen receptor negative cell lines reduced cell viability. These results show that the cytotoxic effects of irisin on prostate cancer cells are not dependent on androgen receptor mechanism.en_US
dc.identifier.citationTEKÄ°N S,ERDEN Y,SANDAL S,YILMAZ B (2015). Is Irisin an Anticarcinogenic Peptide?. Medicine Science, 4(2), 2172 - 2180.en_US
dc.identifier.endpage2180en_US
dc.identifier.issn2147-0634
dc.identifier.issue2en_US
dc.identifier.startpage2172en_US
dc.identifier.trdizinid228580en_US
dc.identifier.urihttps://hdl.handle.net/11616/43819
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/228580
dc.identifier.volume4en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofMedicine Scienceen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleIs Irisin an Anticarcinogenic Peptide?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
Ä°sim:
c502af61-377a-49dd-b4c2-38fb4815e184.pdf
Boyut:
300.21 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
Ä°sim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: